Edition:
United Kingdom

Eyenovia Inc (EYEN.OQ)

EYEN.OQ on NASDAQ Stock Exchange Capital Market

9.55USD
23 Feb 2018
Change (% chg)

$0.05 (+0.53%)
Prev Close
$9.50
Open
$9.50
Day's High
$9.55
Day's Low
$9.18
Volume
1,226
Avg. Vol
--
52-wk High
$10.60
52-wk Low
$8.51

Latest Key Developments (Source: Significant Developments)

Eyenovia Announces Appointment Of John Gandolfo As CFO
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Eyenovia Inc ::EYENOVIA INC - APPOINTMENT OF JOHN GANDOLFO AS CHIEF FINANCIAL OFFICER EFFECTIVE DECEMBER 18, 2017.EYENOVIA ANNOUNCES APPOINTMENT OF JOHN GANDOLFO AS CHIEF FINANCIAL OFFICER.  Full Article

Eyenovia Sees IPO Of 2.73 Mln Shares Of Common Stock Priced Between $10-$12 Per Share
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Eyenovia Inc ::EYENOVIA INC SEES IPO OF 2.73 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $10.00 AND $12.00 PER SHARE - SEC FILING.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $12 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROPROST.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $2 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROSTAT.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $1.5 MILLION TO COMPLETE MICROTEARS REGISTRATION ACTIVITIES.  Full Article

BRIEF-Eyenovia Advances Micropine For Myopia Into Phase III Clinical Development

* EYENOVIA ADVANCES MICROPINE FOR MYOPIA INTO PHASE III CLINICAL DEVELOPMENT AND APPOINTS STANFORD PROFESSOR DR. DOUGLAS FREDRICK TO ITS SCIENTIFIC ADVISORY BOARD AND MYOPIA PROGRAM STEERING COMMITTEE